| Cat.No. | Name | Information |
|---|---|---|
| M8975 | CWHM-12 | CWHM-12 is a potent inhibitor of αV integrins with IC50 values of 0.2, 0.8, 1.5, and 1.8 nM for αvβ8, αvβ3, αvβ6, and αvβ1, respectively. |
| M9173 | Cilengitide trifluoroacetate | Cilengitide is a potent integrin inhibitor for αvβ3 and αvβ5 receptor with IC50 of 4.1 nM, 79 nM in cell-free assays respectively. |
| M2042 | Cilengitide | Cilengitide (EMD 121974, NSC 707544) is a selective inhibitor of αvβ3 integrin and αvβ5 integrin with IC50 of 1 nM and 140 nM, respectively. |
| M2362 | A-205804 | A-205804 is a potent and selective inhibitor of E-selectin and ICAM-1 expression with IC50 of 20 nM and 25 nM respectively. |
| M1618 | Vedolizumab | Vedolizumab is a humanized monoclonal antibody that specifically antagonizes Integrin (α4β7) and inhibits the binding of α4β7 to the intestinal mucosal cell adhesion molecule MADCAM-1. Vedolizumab is indicated for humanized mice. |
| M54412 | HSDVHK-NH2 | HSDVHK-NH2 is an antagonist of the integrin αvβ3-vitronectin interaction, with an IC50 of 1.74 pg/mL (2.414 pM). |
| M54396 | LDV | LDV, a tripeptide, is a non-fluorescent analog of LDV-FITC. |
| M54150 | Cyclo(RADfK) | Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis. |
| M54125 | Obtustatin | Obtustatin is a non-RGD disintegrin of 41 residues. |
| M54054 | Integrin Binding Peptide | Integrin Binding Peptide is derived by fibronectin. |
| M54039 | GRGDSPK | GRGDSPK (EMD 56574) is a peptide incluing Arg-Gly-Asp (RGD). |
| M54038 | Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA | Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) is an integrin αvβ3 inhibitor. |
| M54037 | Cyclo(Arg-Gly-Asp-D-Phe-Cys) | Cyclo(Arg-Gly-Asp-D-Phe-Cys) (Cyclo RGDfC), a cyclic RGD peptide which has high affinity to αvβ3, can disrupt cell integrin interactions. |
| M54021 | Cyclo(RGDyK) | Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with an IC50 of 20 nM. |
| M53932 | Gly-Arg-Gly-Asp-Ser | Gly-Arg-Gly-Asp-Ser is a pentapeptide that forms the cell-binding domain of a glycoprotein, osteopontin. |
| M53341 | α2β1 Integrin Ligand Peptide | α2β1 Integrin Ligand Peptide interacts with the α2β1 integrin receptor on the cell membrane and mediates extracellular signals into cells. |
| M53340 | Gly-Arg-Gly-Asp-Ser TFA | Gly-Arg-Gly-Asp-Ser (TFA) is a pentapeptide that forms the cell-binding domain of a glycoprotein, osteopontin. |
| M53339 | Echistatin | Echistatin, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation. |
| M53338 | KGDS | KGDS is synthetic peptides, targeting integrin GPIIb-IIIa located on the membrane of human activated platelets. |
| M53337 | LXW7 | LXW7, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin αvβ3 inhibitor. |
| M53336 | Synstatin (92-119) | Synstatin (92-119) is an anti-tumor agent that inhibits angiogenesis and cancer cell invasion. |
| M53335 | RGD-4C | RGD-4C is a arginine-glycine-aspartic acid peptide (ACDCRGDCFC) with integrin binding activity. |
| M53334 | FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro | FITC-Ahx Gly Arg Gly Asp Ser Pro is a GRGDSP coupled to FITC. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
